Cancer recurrence is often deadlier than the original disease, especially when it spreads undetected. Yet for survivors, post-treatment monitoring can be a financial, emotional and mental burden—relying on costly, invasive tests with no guarantees. 

But what if detecting cancer was as simple as a blood test? 

In this episode, Dr Debleena Ray, the founder of the biotech startup 2Strands Biosciences and a former Duke-NUS post-doctoral fellow, shares how she’s bridging research and entrepreneurship to develop cutting-edge, blood-based tests that will revolutionise cancer monitoring.   

What’s inside this episode: 

• The story behind 2Strands Biosciences and Ray’s vision for the future of cancer detection 
• How her love for science began—and what fuels her passion 
• The leap from academia to entrepreneurship—and the lessons learned 
• Her advice for aspiring scientist-entrepreneurs looking to make an impact 

Episode credits: 

Hosted by: Brandon Raeburn, Media & Content Specialist 

Produced by: Sean Firoz, Helmy bin Sa’at and Nicole Lim 

To discover more scientific insights and personal stories from Singapore with impact on the world, go to: www.duke-nus.edu.sg/medicus